DSE:SAMORITA

Samorita Hospital Limited announcements

287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (16).

  1. Resumption after record date

    Trading of the shares of the Company will resume on 19.11.2017 after record date.

  2. Suspension for Record Date

    Trading of the shares of the Company will remain suspended on record date i.e., 16.11.2017.

  3. Spot News

    Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 14.11.2017 to 15.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 16.11.2017.

  4. Dividend Declaration

    The Board of Directors has recommended 10% cash and 10% stock dividend for the year ended on June 30, 2017. Date of AGM: 21.12.2017, Time: 11:00 AM, Venue: MH Samorita Hospital & Medical College, 117 Tejgaon, Love Road, Dhaka-1208. Record Date: 16.11.2017. (cont.) (Continuation of news of SAMORITA): The Company has also reported EPS of Tk. 2.34, NAV per share of Tk. 52.30 and NOCFPS of Tk. 4.45 for the year ended on June 30, 2017 as against Tk. 2.06 (restated), Tk. 50.87 (restated) and Tk. 3.56 (restated) respectively for the same period of the previous year. (end)

  5. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (25.10.2017) following its corporate declaration.

  6. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.49 for July-September, 2017 as against Tk. 0.22 for July-September, 2016; NOCFPS was Tk. 0.38 for July-September, 2017 as against Tk. 0.70 for July-September, 2016. NAV per share was Tk. 52.79 as on September 30, 2017 and Tk. 51.09 as on September 30, 2016.

  7. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 24, 2017 at 7:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

  8. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 24, 2017 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

  9. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 0.66 for January-March, 2017 as against Tk. 0.49 for January-March, 2016; EPS was Tk. 1.71 for July, 2016-March, 2017 as against Tk. 1.57 for July, 2015-March, 2016. NOCFPS was Tk. 3.57 for July, 2016-March, 2017 as against Tk. 3.06 for July, 2015-March, 2016. NAV per share was Tk. 51.66 as of March 31, 2017 and Tk. 50.38 as of March 31, 2016.

  10. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 25, 2017 at 8:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

  11. Confirmation of Transmission of Deceased Director's shares

    The Company has informed that 2,09,364 shares i.e. 14/96th portion of 14,35,634 shares of Late Dr. Abu Ahmed Chowdhury, a former Director & Chairman of Samorita Hospital Ltd., has been transmitted to his son Prof. Reaz Ahmed Chowdhury, a general shareholder director of the Company as per Succession Certificate issued by the Honorable Court.

  12. Transmission of Deceased Director's shares to his successor

    The Company has informed that 2,09,364 shares of Late Dr. Abu Ahmed Chowdhury, a former Director & Chairman of Samorita Hospital Ltd. (which is 14/96th portion shares of his total 14,35,634 shares) will be transmitted to his son Prof. Reaz Ahmed Chowdhury, a General Shareholder Director of the Company as per Succession Certificate issued by the Honorable Court, within April 30, 2017.

  13. Q2 Financials

    EPS was Tk. 0.83 for October-December, 2016 as against Tk. 0.49 for October-December, 2015; EPS was Tk. 1.05 for July-December, 2016 as against Tk. 1.08 for July-December, 2015. NOCFPS was Tk. 2.11 for July-December, 2016 as against Tk. 1.68 for July-December, 2015. NAV per share was Tk. 51.01 as of December 31, 2016 and Tk. 49.89 as of December 31, 2015.

  14. Board Meeting

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 24, 2017 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

  15. Dividend Disbursement

    The Company has informed that cash dividend for the year ended on June 30, 2016 has been credited to the respective shareholders' Bank Account through BEFTN system on January 08, 2017.

  16. Query Response

    In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.